Healthcare

Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022

Staff July 28, 2022

Live Conference Call and Webcast at 4:30 p.m. ETPRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX),...

InnerScope Hearing Technologies (OTC: INND) Receives $2.75 Million in Non-Dilutive Financing

Staff July 28, 2022

ROSEVILLE, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), an emerging...

GigaGen Publishes Research Showcasing First-Ever Clinical GMP Manufacturing and IND-Enabling Studies for its New Class of Drugs, Recombinant Polyclonal Antibodies

Staff July 28, 2022

SOUTH SAN FRANCISCO, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for...

Rhythm Pharmaceuticals to Report Second Quarter 2022 Financial Results on Tuesday, August 2, 2022

Staff July 28, 2022

BOSTON, July 28, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the...

Syapse Announces $35 Million Growth Investment with Innovatus Capital Partners to Expand Delivery of Real-World Evidence Through Syapse’s Learning Health Network

Staff July 27, 2022

SAN FRANCISCO and NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing...

Ogilvy Health Bolsters Executive Leadership Team, Recruiting Tyler Montague as EVP, Client Leader

Staff July 27, 2022

Tyler Montague Tyler Montague - EVP, Client Leader.NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- Ogilvy Health today announced Tyler...

Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement

Staff July 27, 2022

WOBURN, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program With 180 Life Sciences Corp.

Staff July 27, 2022

PALO ALTO, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the...

Eyenovia Announces Appointment of Ophthalmic Industry Veteran Michael Rowe as Chief Executive Officer and Board Member

Staff July 27, 2022

Appointment of Mr. Rowe, Eyenovia’s current Chief Operating Officer, maintains continuity while bringing significant ophthalmic industry, operations and commercialization expertise...

LifeMD, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 11, 2022

Staff July 27, 2022

NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced...

Progyny is First Fertility Benefits Solution to Publish Outcomes with Independent Validation

Staff July 27, 2022

Progyny Outcomes Consistently Exceed National Benchmarks Across Key Clinical Measures of Fertility Success Progyny's Superior Clinical Outcomes The outcomes of...

Vaxart Provides New Update on Proxy Voting and Urges All Stockholders of Record as of April 11, 2022, to Vote by August 3, 2022, at 11:59 p.m. ET

Staff July 27, 2022

Key Proposal #2 Needs an Additional 0.9% of Outstanding Shares Votes to Pass Leading Independent Proxy Advisory Firms, ISS and...

Sensus Healthcare Takes Order for 10 TransDermal Infusion Systems™ Supporting Hair Enhancement Centers Expansion Along with U.SK Under Skin’s Hair-Health Serum

Staff July 27, 2022

BOCA RATON, Fla., July 27, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in...

Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Over-Year and Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.

Staff July 27, 2022

Oak Ridge, TN, July 27, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement...

MIMEDX Announces Formation of Regenerative Medicine Scientific Advisory Board Comprised of Renowned Industry and Academic Experts

Staff July 27, 2022

Scientific Advisory Board Adds Multi-disciplinary Clinical and Scientific Expertise to Support Acceleration of the Company’s mdHACM Placental Biologics Pipeline MARIETTA,...

Healthcare

Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022

InnerScope Hearing Technologies (OTC: INND) Receives $2.75 Million in Non-Dilutive Financing

GigaGen Publishes Research Showcasing First-Ever Clinical GMP Manufacturing and IND-Enabling Studies for its New Class of Drugs, Recombinant Polyclonal Antibodies

Rhythm Pharmaceuticals to Report Second Quarter 2022 Financial Results on Tuesday, August 2, 2022

Syapse Announces $35 Million Growth Investment with Innovatus Capital Partners to Expand Delivery of Real-World Evidence Through Syapse’s Learning Health Network

Ogilvy Health Bolsters Executive Leadership Team, Recruiting Tyler Montague as EVP, Client Leader

Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement

180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program With 180 Life Sciences Corp.

Eyenovia Announces Appointment of Ophthalmic Industry Veteran Michael Rowe as Chief Executive Officer and Board Member

LifeMD, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 11, 2022

Progyny is First Fertility Benefits Solution to Publish Outcomes with Independent Validation

Vaxart Provides New Update on Proxy Voting and Urges All Stockholders of Record as of April 11, 2022, to Vote by August 3, 2022, at 11:59 p.m. ET

Sensus Healthcare Takes Order for 10 TransDermal Infusion Systems™ Supporting Hair Enhancement Centers Expansion Along with U.SK Under Skin’s Hair-Health Serum

Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Over-Year and Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.

MIMEDX Announces Formation of Regenerative Medicine Scientific Advisory Board Comprised of Renowned Industry and Academic Experts

Nuvectis Pharma, Inc. Announces Approximately $15.9 Million Private Placement

Alimera Sciences Announces Second Quarter 2022 Financial Results

Nephros Second Quarter 2022 Financial Results Conference Call

vTv Therapeutics Announces Paul Sekhri as new President and Chief Executive Officer

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022

Digicann Ventures Signs Definitive Agreement for Proposed RTO Transaction with 3Win Corp.

Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease

Next Health Announces Proactive Healthcare and Longevity Centers Coming Soon to Tampa and St. Petersburg

Quantum Biopharma Provides Corporate Update

You may have missed